Avicanna Inc., a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that its RHO Phyto and Pura Earth branded topicals have attained initial listings and commenced sales in the Canadian province of Alberta.
As part of the development process, Avicanna’s topicals have gone through various pre-clinical and clinical evaluation before being released to the market. These complex and proprietary topical products are developed through Avicanna’s renowned R&D platform and formulated to deliver cannabinoids with synergistic natural active ingredients with long term shelf-life stability, consistency, and enhanced absorption. Avicanna’s topical formulations are developed starting with the cannabinoids in the oil phase – a process that is critical in preventing degradation, ensuring homogeneity, and increasing absorption of cannabinoids into the skin. Avicanna’s research team brings years of product development and topical formulation expertise and have developed dozens of SKUs of cosmetics, medical and pharmaceutical preparations that available in several countries.
Aras Azadian, Avicanna’s CEO, commented: “We are thrilled to enter another major Canadian province with several of our proprietary products and two of our brands. With the emergence of cannabis 2.0 products, the market has been saturated with low quality products such as topicals, which are often produced by infusing cannabis extract into a preformulated based cream. This has been to the detriment of emerging wellness segment within the Canadian cannabis industry and a source of disappointment to the consumers who have high expectations for such products. Our market approach is to deliver these proprietary products with the support of appropriate education and training to all stakeholders. This approach will be a driving force in the establishment and growth of the wellness category and market for functional cannabinoid-based products.”
Pura Earth Products Overview
An advanced and clinically tested line of CBD consumer derma-cosmetic products, these unique formulations are THC-Free, dermatologist tested for irritation, cruelty-free and vegan. The fast-absorbing, formulas combine pure CBD with natural ingredients providing functional benefits for specific needs. Pura Earth products fit into any daily self-care routine and can be used in conjunction with other skincare products.
RHO Phyto Extra Strength Deep Tissue Gel Overview
The gel is part of the most complete and advanced medical cannabis formulary including oral, sublingual and topical products with proven success in the medical channels across Canada, including Medical Cannabis by Shoppers, and the first formulary to be available in a major Canadian hospital, Sunnybrook Health Sciences Center in Toronto.
The advanced emulsion formula has proven deep tissue delivery and increased absorption into deeper layers of the skin. The fast-absorbing, water-based formula synergistically combines cannabinoids and functional natural terpenes including menthol and clove oil which contains eugenol and beta-caryophyllene. This formulation is currently in ongoing preclinical studies evaluating the efficacy of the Deep Tissue gel for attenuating pain and inflammation in osteoarthritis. In addition, the gel is enrolled in the observational Medical Cannabis Real World Evidence Study for patients with chronic pain conducted by the University Health Network.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.